middle.news
Actinogen Validates 10 mg Xanamem Dose in Peer-Reviewed Clinical Study
1:34pm on Thursday 6th of February, 2025 AEDT
•
Biotechnology
Read Story
Actinogen Validates 10 mg Xanamem Dose in Peer-Reviewed Clinical Study
1:34pm on Thursday 6th of February, 2025 AEDT
Key Points
Peer-reviewed publication confirms 10 mg daily Xanamem dose
Clinical pharmacology approach integrates PET and cognitive testing
Positive phase 2a depression trial results support dose selection
XanaMIA phase 2b/3 Alzheimer's trial underway with 10 mg dose
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Actinogen Medical (ASX:ACW)
OPEN ARTICLE